In contrast to the innovations in cancer treatments that help drive improved survival, there are far fewer innovations targeting toxicities and providing supportive care.
Hong Tang, MD, FACP
Advertisement
Hong Tang, MD, FACP, is the chief medical officer of OnQuality Pharmaceuticals, LLC.
Articles by Hong Tang, MD, FACP
Advertisement
Latest Updated Articles
Skin Toxicity in Cancer Treatment: A Critical Part of Cancer Supportive CarePublished: October 1st 2021 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
